STAT+: Boston’s most valuable biotech? It’s not who you might expect
The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies.
While many biotech stocks have struggled this year amid a broader economic downturn, Vertex Pharmaceuticals has risen 65 percent since its most recent low in October 2021. And the 33-year-old firm is now Boston’s most valuable biotech by a mile.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Boston’s most valuable biotech? It’s not who you might expect »
